CClinicalTrials.gg
Status unknownNCT05792969IMPAssNEGLECTUpdated Mar 31, 2023

Public Health Impact of Unilateral Spatial Neglect

An observational study in Spatial Neglect, sponsored by Istituto Auxologico Italiano. Status unknown at 1 site in Italy. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-03-31.

Sponsored by Istituto Auxologico Italiano · Observational

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
168
Ages
18 Years to 99 Years
Sex
All
01

Study summary

This multi-center project aims to quantify the socio-medical costs associated with Unilateral Spatial Neglect (USN) resulting from acquired brain injury (stroke) and to measure the effects of USN rehabilitation on functional autonomy, quality of life and psychological well-being of patients affected by this syndrome, considering the repercussions on a psychological level and on the quality of life of caregivers.

To this end, the experimenters will administer to right brain-injured patients - with (Experimental Group) or without (Control Group) USN - who undertook a rehabilitation process, a series of questionnaires: Activities of daily living (ADL), Barthel Index; Instrumental activities of daily living scale (I-ADL:), the Health Related Quality of Life questionnaire (EQ-5D-5L), the Geriatric Depression Scale (GDS), and the State-Trait Anxiety Inventory (STAI-Y). The aforementioned tests will be administered before the start of the rehabilitation (baseline) and after one month, 3, 6 and 12 months after the end of the rehabilitation. The impact of USN and its treatment on the psycho-physical well-being of the caregiver will be measured through the Caregiver Burden Inventory questionnaire, which will be administered with the same timing (baseline, 1-3-6-12 months after rehabilitation). The costs of USN will be surveyed through an ad-hoc questionnaire, which includes a version intended for patients and one for caregivers, in order to identify the resources consumed due to the disease and the expenses taken during the observation period, to be estimated subsequently in monetary terms (€).

02

Conditions studied

  • Spatial Neglect

Browse trials for

03

In context

Perceptual Disorders

92 studies on the registry are indexed under Perceptual Disorders; 23 are open to participants now.

This study's planned enrollment of 168 is above the median of 80 across 19 observational studies indexed under Perceptual Disorders.

Browse Perceptual Disorders studies →

Lead sponsor

Istituto Auxologico Italiano is the lead sponsor of 196 studies on the registry; 78 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Stroke patients with and without USN and their caregivers

Inclusion criteria

  • age > 18 years;
  • right brain injury due to stroke (of ischemic or hemorrhagic origin);
  • Disease duration ≥ 10 days;
  • Participation to a rehabilitation program;

For stroke patients with USN:

  • clinical diagnosis of USN, placed by the specialist of reference, on the basis of clinical indicators and the results obtained by the patient in the routine neuropsychological evaluation (by means of a battery of standardized psychometric tests calibrated in the Italian population).

Exclusion criteria

Exclusion Criteria:

  • Other brain disorders
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
168 participants (estimated)
Patient registry
No

Groups and cohorts

  • Stroke patients with USN and their caregivers

    Behavioral: Functional measures and public health outcomes

  • Stroke patients without USN and their caregivers

    Behavioral: Functional measures and public health outcomes

Interventions

  • BehavioralFunctional measures and public health outcomes

    Questionnaires: * Activities of daily living - ADL * Barthel Index * Instrumental activities of daily living- IADL * Health Related Quality of Life - EQ-5D-5L * Geriatric Depression Scale (GDS) * State-Trait Anxiety Inventory - STAI-Y) * Caregiver Burden Inventory questionnaire (CBI)

06

What researchers measure

Primary outcomes

  1. Change in the Activities of Daily Living scale (ADL)

    To evaluate the degree of patients' functional independence in everyday life

    Time frame: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  2. Change in the Instrumental Activities of Daily Living scale (I-ADL)

    To evaluate the degree of patients' functional independence instrumental activities, including, e.g., cleaning, cooking, and managing finances.

    Time frame: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  3. Change in the Health-Related Quality of Life (EQ-5D-5L)

    A brief scale assessing patient's health-related quality of life

    Time frame: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  4. Change in the Geriatric Depression Scale (GDS)

    A scale assessing patients' depressive symptoms

    Time frame: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  5. Change in the State-Trait Anxiety Inventory (STAI-Y)

    A scale assessing patients' anxiety symptoms

    Time frame: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  6. Change in the Caregiver Burden Inventory questionnaire (CBI)

    A scale that assess caregivers' physical and psychological burden

    Time frame: At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatment

  7. Financial impact of USN

    A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)

    Time frame: 1 month after the end of the treatment

  8. Financial impact of USN

    A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)

    Time frame: 3 months after the end of the treatment

  9. Financial impact of USN

    A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)

    Time frame: 6 months after the end of the treatment

  10. Financial impact of USN

    A questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)

    Time frame: 12 months after the end of the treatment

07

Study locations

1 of 1 sites recruiting
  • Istituto Auxologico Italiano IRCCS
    Milan, Lombardia 20122, Italy
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 31, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05792969
Lead sponsor
Istituto Auxologico Italiano
Responsible party
Sponsor
First posted
Mar 31, 2023
Start date
Feb 7, 2022
Primary completion
Nov 30, 2024 (estimated)
Completion
Nov 30, 2024 (estimated)
Last update
Mar 31, 2023

Study contacts

Nadia Bolognini, PhD
Contact
n.bolognini@auxologico.it
+39025821 ext. 8132

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion